UnitedHealth's newly returned CEO, Stephen Hemsley, will likely face investor scrutiny over the largest U.S. health insurance ...

The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...

Investors will be looking for a path to a turnaround from UnitedHealth’s earnings release, after an abrupt CEO change and ...

Bretton Fund reviews Q2 setbacks led by UnitedHealth’s plunge, offset by gains from Microsoft and AmEx. See how fundamentals ...

UnitedHealth Group (NYSE:UNH) will report Q2 results on Tuesday, July 29, in what is shaping up to be one of its most ...

Number of returning bosses reaches 10-year high despite data suggesting second stints are rarely as successful ...

On Thursday, the giant health care conglomerate announced that it had “proactively reached out” to the Justice Department, ...

UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency.

UnitedHealth Group confirmed that its Medicare Advantage program is under investigation by the U.S. Department of Justice.

UnitedHealth Group confirmed Thursday the company is facing criminal and civil investigations from the Department of Justice ...

The disclosure sent UNH shares tumbling 4.7%, reflecting investor unease with the ongoing troubles with the healthcare stock.

The U.S. Department of Justice’s (DOJ) criminal healthcare-fraud unit has intensified its investigation into UnitedHealth ...